当前位置:首页 - 行情中心 - 博拓生物(688767) - 财务分析 - 现金流量表

博拓生物

(688767)

  

流通市值:61.14亿  总市值:61.14亿
流通股本:1.49亿   总股本:1.49亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金207,358,345.789,620,712.2465,654,975.3342,177,119.33
  收到的税费返还11,508,509.025,816,514.5451,382,689.1819,300,948.66
  收到其他与经营活动有关的现金18,130,392.1111,642,012.5956,986,608.1331,319,736.5
  经营活动现金流入小计236,997,246.83107,079,239.33574,024,272.61392,797,804.49
  购买商品、接受劳务支付的现金101,765,859.2663,686,666.69233,804,822.92163,682,920.12
  支付给职工以及为职工支付的现金69,185,873.7836,420,120.36123,291,462.6588,408,999.57
  支付的各项税费12,856,525.9711,607,527.8421,075,653.7423,398,251.99
  支付其他与经营活动有关的现金45,074,616.6713,353,456.8989,384,232.8643,234,150.81
  经营活动现金流出小计228,882,875.68125,067,771.78467,556,172.17318,724,322.49
  经营活动产生的现金流量净额8,114,371.15-17,988,532.45106,468,100.4474,073,482
二、投资活动产生的现金流量:
  收回投资收到的现金1,998,100,000908,500,0005,471,665,787.444,336,866,600
  取得投资收益收到的现金2,429,596.461,203,750.157,001,322.735,753,210.89
  处置固定资产、无形资产和其他长期资产收回的现金净额22,090.91-2,741,395.442,175,000
  投资活动现金流入小计2,000,551,687.37909,703,750.155,481,408,505.614,344,794,810.89
  购建固定资产、无形资产和其他长期资产支付的现金31,012,511.9922,534,904129,870,805.9367,005,080.47
  投资支付的现金1,752,896,511.81936,312,8805,219,834,232.163,763,915,892.5
  投资活动现金流出小计1,783,909,023.8958,847,7845,349,705,038.093,830,920,972.97
  投资活动产生的现金流量净额216,642,663.57-49,144,033.85131,703,467.52513,873,837.92
三、筹资活动产生的现金流量:
  吸收投资收到的现金2,640,0002,640,000--
  其中:子公司吸收少数股东投资收到的现金2,640,0002,640,000--
  取得借款收到的现金100,000,000---
  收到其他与筹资活动有关的现金0-3,147,5003,147,500
  筹资活动现金流入小计102,640,0002,640,0003,147,5003,147,500
  偿还债务支付的现金477,187.98--249,872.17
  分配股利、利润或偿付利息支付的现金104,673,333.8-159,875,000.5159,875,000.5
  支付其他与筹资活动有关的现金110,642,812.02-1,329,402.641,325,772.72
  筹资活动现金流出平衡项目0-00
  筹资活动现金流出小计215,793,333.8-161,204,403.14161,450,645.39
  筹资活动产生的现金流量净额-113,153,333.82,640,000-158,056,903.14-158,303,145.39
四、汇率变动对现金及现金等价物的影响-32,503,908.83-17,537,266.19-12,677,811.46-9,947,456.31
五、现金及现金等价物净增加额79,099,792.09-82,029,832.4967,436,853.36419,696,718.22
  加:期初现金及现金等价物余额1,171,196,284.521,171,196,284.521,103,759,431.161,103,759,431.16
  期末现金及现金等价物余额1,250,296,076.611,089,166,452.031,171,196,284.521,523,456,149.38
补充资料:
  净利润-17,094,519.68-47,126,834.92-
  资产减值准备1,959,553.85-5,763,033.17-
  固定资产和投资性房地产折旧11,700,129.27-23,314,377.73-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧11,700,129.27-23,314,377.73-
  无形资产摊销2,761,745.35-955,984.56-
  处置固定资产、无形资产和其他长期资产的损失8,531.25--247,488.75-
  固定资产报废损失106,444.85-42,136.44-
  公允价值变动损失-353,518.3--320,319.1-
  财务费用36,501,746.79-12,975,556.21-
  投资损失1,554,820.42--3,969,405.85-
  递延所得税-6,632,830.05-1,696,537.09-
  其中:递延所得税资产减少-6,632,830.05-1,696,537.09-
  存货的减少-2,007,190.92--2,042,273.7-
  经营性应收项目的减少-4,961,033.61-3,785,137.83-
  经营性应付项目的增加-16,350,241.78-8,842,273.47-
  其他102,544.68-8,782,558.19-
  现金的期末余额1,250,296,076.61-1,171,196,284.52-
  减:现金的期初余额1,171,196,284.52-1,103,759,431.16-
  现金及现金等价物的净增加额79,099,792.09-67,436,853.36-
公告日期2026-08-292026-04-252026-04-252025-10-30
审计意见(境内)标准无保留意见
TOP↑